Catherine Drew is an intellectual property associate who joined the firm’s London office in 2011.
Ms. Drew has experience in large-scale, multi-jurisdictional patent litigation. She has been involved at all stages of litigation in the English High Court, Court of Appeal, and Supreme Court and has advised on coordination of wider European patent litigation strategies.
Ms. Drew’s practice combines experience in intellectual property law and European medicines regulatory law, taking a “full-picture” approach in considering all potential exclusivity rights to which a product may be entitled. She has advised on many aspects of European medicines regulation such as Supplementary Protection Certificates, data exclusivity, and orphan exclusivity. Ms Drew has also advised on matters such as product liability and the legal issues around the marketing of medicinal and cosmetic products. In addition to identifying opportunities in this field for clients, Ms. Drew has experience of seeking judicial review of decisions of the European Medicines Agency before the European General Court.
Ms. Drew has also worked on non-contentious aspects of intellectual property law including advising on the intellectual property issues arising out of commercial agreements, such as those for the supply, manufacture, and marketing of products. Prior to joining Winston & Strawn Ms. Drew gained experience in-house with one of the world’s largest pharmaceutical manufacturers coordinating patent litigation throughout Europe.
Ms. Drew received a B.A. Hons in Natural Sciences from Cambridge University in 2003. She received her Graduate Diploma in Law and Legal Practice Certificate from Nottingham Law School in 2005 and received her Post Graduate Diploma in Intellectual Property Law from the University of Bristol in 2007.